Parametric Portfolio Associates LLC raised its stake in shares of Anthem, Inc. (NYSE:ANTM) by 0.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,164,693 shares of the company’s stock after purchasing an additional 8,356 shares during the quarter. Parametric Portfolio Associates LLC owned 0.45% of Anthem worth $221,152,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors also recently made changes to their positions in ANTM. Janus Henderson Group PLC lifted its position in Anthem by 2,835.4% during the second quarter. Janus Henderson Group PLC now owns 1,161,736 shares of the company’s stock valued at $218,554,000 after purchasing an additional 1,122,159 shares during the last quarter. JPMorgan Chase & Co. lifted its position in Anthem by 177.3% during the second quarter. JPMorgan Chase & Co. now owns 1,269,249 shares of the company’s stock valued at $238,783,000 after purchasing an additional 811,537 shares during the last quarter. UBS Asset Management Americas Inc. lifted its position in Anthem by 80.6% during the second quarter. UBS Asset Management Americas Inc. now owns 1,583,761 shares of the company’s stock valued at $297,953,000 after purchasing an additional 706,775 shares during the last quarter. BlueMountain Capital Management LLC lifted its position in Anthem by 12,287.7% during the second quarter. BlueMountain Capital Management LLC now owns 596,715 shares of the company’s stock valued at $112,260,000 after purchasing an additional 591,898 shares during the last quarter. Finally, Assenagon Asset Management S.A. bought a new stake in Anthem during the third quarter valued at approximately $101,758,000. Institutional investors and hedge funds own 87.75% of the company’s stock.
Shares of Anthem, Inc. (ANTM) opened at $227.12 on Friday. The firm has a market cap of $59,583.84, a P/E ratio of 18.62, a PEG ratio of 1.82 and a beta of 0.79. The company has a quick ratio of 1.51, a current ratio of 1.51 and a debt-to-equity ratio of 0.53. Anthem, Inc. has a 1-year low of $140.50 and a 1-year high of $236.39.
Anthem (NYSE:ANTM) last announced its quarterly earnings data on Wednesday, October 25th. The company reported $2.65 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.40 by $0.25. The firm had revenue of $22.10 billion during the quarter, compared to analyst estimates of $22.10 billion. Anthem had a net margin of 3.35% and a return on equity of 12.97%. The business’s quarterly revenue was up 4.6% on a year-over-year basis. During the same period in the previous year, the business posted $2.45 EPS. research analysts predict that Anthem, Inc. will post 11.97 earnings per share for the current year.
Anthem declared that its Board of Directors has approved a stock repurchase program on Thursday, December 7th that permits the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization permits the company to repurchase shares of its stock through open market purchases. Shares repurchase programs are usually an indication that the company’s leadership believes its shares are undervalued.
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 21st. Stockholders of record on Tuesday, December 5th will be issued a $0.70 dividend. The ex-dividend date of this dividend is Monday, December 4th. This represents a $2.80 dividend on an annualized basis and a dividend yield of 1.23%. Anthem’s payout ratio is 25.32%.
In related news, Director Julie A. Hill sold 1,602 shares of Anthem stock in a transaction on Tuesday, November 7th. The shares were sold at an average price of $215.70, for a total value of $345,551.40. Following the transaction, the director now directly owns 35,322 shares of the company’s stock, valued at $7,618,955.40. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Joseph Swedish sold 21,125 shares of Anthem stock in a transaction on Monday, October 2nd. The stock was sold at an average price of $190.63, for a total transaction of $4,027,058.75. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 65,955 shares of company stock worth $13,907,287. 0.36% of the stock is owned by insiders.
ANTM has been the subject of several research analyst reports. B. Riley reiterated a “buy” rating on shares of Anthem in a research report on Wednesday, December 6th. Jefferies Group lifted their target price on shares of Anthem from $204.00 to $211.00 and gave the company a “hold” rating in a research report on Friday, October 13th. Zacks Investment Research upgraded shares of Anthem from a “hold” rating to a “buy” rating and set a $207.00 target price for the company in a research report on Wednesday, September 20th. Morgan Stanley lifted their target price on shares of Anthem from $196.00 to $201.00 and gave the company an “equal weight” rating in a research report on Thursday, August 17th. Finally, Credit Suisse Group initiated coverage on shares of Anthem in a research report on Thursday, November 2nd. They set an “outperform” rating and a $234.00 target price for the company. Eight investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $201.07.
WARNING: This story was first posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this story on another site, it was illegally copied and reposted in violation of U.S. and international copyright laws. The correct version of this story can be viewed at https://ledgergazette.com/2017/12/15/parametric-portfolio-associates-llc-has-221-15-million-stake-in-anthem-inc-antm.html.
Anthem, Inc is a health benefits company. The Company operates through three segments: Commercial and Specialty Business, Government Business and Other. It offers a spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products.
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.